Letter to the Editor| Volume 86, ISSUE 3, P256-308, March 2023

Facial nerve palsy as a possible adverse drug reaction of the modified vaccinia ankara-bavarian nordic (MVA-BN) smallpox vaccine: A pharmacovigilance analysis

Published:January 08, 2023DOI:
      Facial nerve palsy; Bell's palsy; Monkeypox; Adverse drug reaction; Pharmacovigilance


      vaccine (vaccine)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rao Agam K.
        Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022.
        MMWR Morb Mortal Wkly Rep. 2022; 71 (Doi)
        • Yuan-Pin Hung
        • Ching-Chi Lee
        • Jen-Chieh Lee
        • Chun-Wei Chiu
        • Po-Ren Hsueh
        • Wen-Chien Ko
        A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
        J Microbiol Immunol Infect. 2022; (Doi:)
      1. EMA. IMVANEX, modified vaccinia ankara virus - Assessment report 2022:121.

        • Overton Edgar
        • Turner Stapleton
        • Jack Frank
        • Ian Hassler
        • Shawn Goepfert
        • Paul A
        • David Barker
        • et al.
        Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
        Open Forum Infect Dis. 2015; 2 (Doi:): ofv040
      2. Monkeypox : le point sur le virus - Ministère de la Santé et de la Prévention. Available at Accessed November 27, 2022, n.d.

        • Claire Foirest
        • Kévin Bihan
        • Frédéric Tankéré
        • Helga Junot
        • Sophie Demeret
        • Rabab Debs
        • et al.
        Peripheral facial palsy following COVID-19 vaccination: a practical approach to use the clinical situation as a guide.
        Acta Otorhinolaryngol Ital Organo Uff Della Soc Ital Otorinolaringol E Chir Cerv-Facc. 2022; 42 (Doi:): 300-303
        • Lucie Renoud
        • Charles Khouri
        • Bruno Revol
        • Marion Lepelley
        • Justine Perez
        • Matthieu Roustit
        • et al.
        Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
        JAMA Intern Med. 2021; (Doi:)
        • Rana Shibli
        • Ofra Barnett
        • Zomoroda Abu-Full
        • Naomi Gronich
        • Ronza Najjar-Debbiny
        • Ilana Doweck
        • et al.
        Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study.
        Lancet Reg Health Eur. 2021; 11 (Doi:)100236
        • Thomas Soeiro
        • Francesco Salvo
        • Antoine Pariente
        • Aurélie Grandvuillemin
        • Annie-Pierre Jonville-Béra
        • Joëlle Micallef
        Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
        Therapie. 2021; 76 (Doi:): 365-367
        • Sejvar James J.
        • Labutta Robert J.
        • Chapman Louisa E.
        • Grabenstein John D.
        • John Iskander
        • Michael Lane J.
        Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002-2004.
        JAMA. 2005; 294 (Doi:): 2744-2750